Related Experiment Videos
Molecular modelling of C3 and its ligands
1Department of Biochemistry, Oxford University, UK.
Current Topics in Microbiology and Immunology
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Extension of resolution and oligomerization-state studies of 2,4'-dihydroxyacetophenone dioxygenase from Alcaligenes sp. 4HAP.
Acta crystallographica. Section F, Structural biology communications·2015
Targeted Modulation of Lipid Mediator-Biosynthetic Enzymes as Strategy for Inflammation Resolution Pharmacology.
Current topics in microbiology and immunology·2026
Bacterial Infections: Host Defense and Inflammation Resolution Mechanisms for Therapy.
Current topics in microbiology and immunology·2026
Neuronal Guidance Proteins in the Fundamental Biology of Inflammation Resolution.
Current topics in microbiology and immunology·2026
Resolution Failure in Periodontal Diseases: Dysregulated Pro-resolving Mechanisms in Chronic Inflammation and Tissue Breakdown.
Current topics in microbiology and immunology·2026
Resolution Biology in Soft Tissue Joint Disease.
Current topics in microbiology and immunology·2026
A 25+ Year Journey on Yeast-Regulated Cell Death Research.
Current topics in microbiology and immunology·2026
Three-Dimensional Descriptions of π/π, CH/π, and Halogen/π Interactions Formed between Phenyl Substructures.
The journal of physical chemistry. B·2026
Fast activity prediction of chemically modified siRNAs via structure-based energy calculations and inference-augmented tabular deep learning.
Molecular therapy. Nucleic acids·2026
Bicyclo[1.1.1]pentane as a Phenyl Isosteric Replacement.
ACS medicinal chemistry letters·2026
Conformationally constrained 6‑aryl‑1‑(3,4,5‑trimethoxyphenyl)-1H-pyrazolo[3,4‑b]pyrazines as novel microtubule destabilizers: design, synthesis, and antitumor evaluation.
Journal of enzyme inhibition and medicinal chemistry·2026
Structure- and Ligand-Based Discovery of Novel Non-Arginine-Based DDAH1 Inhibitors with Anti-Triple-Negative Breast Cancer Activity.
ACS medicinal chemistry letters·2026